John III - Crestwood Equity Ex CFO
Insider
John III is Ex CFO of Crestwood Equity Partners
| Phone | 832 519 2200 |
| Web | https://www.crestwoodlp.com |
Crestwood Equity Management Efficiency
The company has return on total asset (ROA) of 0.0341 % which means that it generated a profit of $0.0341 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1117 %, meaning that it created $0.1117 on every $100 dollars invested by stockholders. Crestwood Equity's management efficiency ratios could be used to measure how well Crestwood Equity manages its routine affairs as well as how well it operates its assets and liabilities.Crestwood Equity Partners currently holds 3.41 B in liabilities with Debt to Equity (D/E) ratio of 1.25, which is about average as compared to similar companies. Crestwood Equity Partners has a current ratio of 1.31, which is within standard range for the sector. Note, when we think about Crestwood Equity's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Todd Lohrmann | DT Midstream | N/A | |
| Crystal Sled | Western Midstream Partners | N/A | |
| Daniel Holderman | Western Midstream Partners | 45 | |
| C Hagedorn | MPLX LP | 44 | |
| J Symonds | Plains All American | 78 | |
| Rick Hessling | MPLX LP | 58 | |
| James Perry | Energy Transfer LP | 69 | |
| Robert Moss | Enterprise Products Partners | N/A | |
| Frederick Forthuber | Western Midstream Partners | N/A | |
| J Stice | MPLX LP | 61 | |
| Dwayne Wilson | DT Midstream | 62 | |
| Christopher Curia | Energy Transfer LP | 69 | |
| Paul Flynn | Enterprise Products Partners | N/A | |
| Natalie Gayden | Enterprise Products Partners | N/A | |
| Wendy Ellis | DT Midstream | 59 | |
| Lawrence Ziemba | Plains All American | 63 | |
| Richard Redmond | DT Midstream | 64 | |
| Kevin Ramsey | Enterprise Products Partners | N/A | |
| Brian Partee | MPLX LP | 51 | |
| Robert Skaggs | DT Midstream | 71 | |
| Maryann Mannen | MPLX LP | 61 | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0341 |
Crestwood Equity Partners Leadership Team
Elected by the shareholders, the Crestwood Equity's board of directors comprises two types of representatives: Crestwood Equity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Crestwood. The board's role is to monitor Crestwood Equity's management team and ensure that shareholders' interests are well served. Crestwood Equity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Crestwood Equity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Brown, Director of the General Partner | ||
| Diaco Aviki, Chief Operating Officer, Executive Vice President of the Partnership | ||
| Alvin Bledsoe, Independent Director of the General Partner | ||
| Steven Dougherty, Executive Vice President, Chief Accounting Officer of the General Partner | ||
| Clay Williams, Independent Director of the General Partner | ||
| Andrew Thorington, VP Relations | ||
| Joel Lambert, Executive Vice President, Chief Legal, Compliance and Safety Officer of the General Partner | ||
| Deana Werkowitch, Technology Audit | ||
| Joanne Howard, Senior Vice President of Sustainability and Corporate Communications | ||
| John Jacobi, Independent Director of the General Partner | ||
| John Sherman, Independent Director of the General Partner | ||
| Robert Phillips, Chairman of Crestwood Equity GP LLC, CEO of Crestwood Equity GP LLC and President of Crestwood Equity GP LLC | ||
| Gary Reaves, Director of the General Partner | ||
| Warren Gfeller, Lead Independent Director of the General Partner | ||
| Janeen Judah, Independent Director of the general partner | ||
| David Lumpkins, Independent Director of the General Partner | ||
| William Moore, Executive Vice President - Corporate Strategy of the General Partner | ||
| Robert Halpin, Chief Financial Officer, Executive Vice President of the general partner | ||
| John III, Ex CFO | ||
| Angela Minas, Independent Director of the General Partner | ||
| Frances Vallejo, Independent Director of the General Partner | ||
| N Lancaster, Independent Director of the General Partner | ||
| Robert III, President |
Crestwood Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Crestwood Equity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0341 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 7.32 B | |||
| Shares Outstanding | 105.1 M | |||
| Shares Owned By Insiders | 10.79 % | |||
| Shares Owned By Institutions | 53.17 % | |||
| Number Of Shares Shorted | 1.49 M | |||
| Price To Earning | 6.31 X |
Pair Trading with Crestwood Equity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crestwood Equity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crestwood Equity will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Eli Lilly could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eli Lilly when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eli Lilly - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eli Lilly and to buy it.
The correlation of Eli Lilly is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eli Lilly moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eli Lilly moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eli Lilly can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Crestwood Stock
If you are still planning to invest in Crestwood Equity Partners check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Crestwood Equity's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |